Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a unified Locations section with site entries for California, District of Columbia, Maryland, and Pennsylvania. Removed the California Locations, District of Columbia Locations, Maryland Locations, Pennsylvania Locations subpages and the HHS Vulnerability Disclosure link.SummaryDifference0.5%
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.3.2 is displayed, replacing v3.3.1. No changes to study details or results are observed.SummaryDifference0.0%
- Check45 days agoChange DetectedThe site version updates from v3.2.0 to v3.3.1. There are no visible changes to study data, content, or page functionality.SummaryDifference0.0%
- Check53 days agoChange DetectedDeletion removes a government funding status notice about NIH Clinical Center operations; it does not affect the study details or other core content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check67 days agoChange DetectedThe screenshots show minor formatting changes (layout or styling) without altering the study's actual details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.